Literature DB >> 29500546

A gender dimorphism in up-regulation of BACE1 gene expression in schizophrenia.

Nafiseh Nafisi-Far1,2, Soudeh Ghafouri-Fard3, Akram Sadat Tabatabaei Panah2, Arezou Sayad4, Mohammad Taheri5,6.   

Abstract

Schizophrenia has long been considered as a devastating brain disorder in which both genetic and environmental factors are involved. The BACE1 gene is one of the most important susceptibility genes for this disorder. However, the changes in BACE1 expression in schizophrenic patients compared with healthy subjects have not been evaluated yet. In this case-control study, we examined BACE1 expression in a group of 50 patients with schizophrenia and 50 healthy controls. The level of BACE1 gene expression was measured using Real-Time PCR. Substantial increase in gene expression was detected in the patients compared with normal individuals (P = 0.001). Furthermore, a gender dimorphism was observed in BACE1 gene expression in the patients in a way that the male patients manifested a statistically significant higher levels of BACE1 expression (P = 0.002). BACE1 might be implicated in the pathogenesis of schizophrenia. Besides, BACE1 physiology may be gender -based at some levels. Our findings warrant an investigation of BACE1 gene in a larger number of cases and controls.

Entities:  

Keywords:  BACE1; Dimorphism; Gender; Schizophrenia

Mesh:

Substances:

Year:  2018        PMID: 29500546     DOI: 10.1007/s11011-018-0205-7

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  21 in total

1.  Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia.

Authors:  Adel Barakat; Brian Dean; Elizabeth Scarr; Geneviève Evin
Journal:  Schizophr Res       Date:  2010-12       Impact factor: 4.939

2.  Identification of a novel aspartic protease (Asp 2) as beta-secretase.

Authors:  I Hussain; D Powell; D R Howlett; D G Tew; T D Meek; C Chapman; I S Gloger; K E Murphy; C D Southan; D M Ryan; T S Smith; D L Simmons; F S Walsh; C Dingwall; G Christie
Journal:  Mol Cell Neurosci       Date:  1999-12       Impact factor: 4.314

3.  Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.

Authors:  R Yan; M J Bienkowski; M E Shuck; H Miao; M C Tory; A M Pauley; J R Brashier; N C Stratman; W R Mathews; A E Buhl; D B Carter; A G Tomasselli; L A Parodi; R L Heinrikson; M E Gurney
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

4.  Purification and cloning of amyloid precursor protein beta-secretase from human brain.

Authors:  S Sinha; J P Anderson; R Barbour; G S Basi; R Caccavello; D Davis; M Doan; H F Dovey; N Frigon; J Hong; K Jacobson-Croak; N Jewett; P Keim; J Knops; I Lieberburg; M Power; H Tan; G Tatsuno; J Tung; D Schenk; P Seubert; S M Suomensaari; S Wang; D Walker; J Zhao; L McConlogue; V John
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

5.  Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade.

Authors:  Saurav Seshadri; Atsushi Kamiya; Yukako Yokota; Ingrid Prikulis; Shin-ichi Kano; Akiko Hayashi-Takagi; Amelia Stanco; Tae-Yeon Eom; Sarada Rao; Koko Ishizuka; Philip Wong; Carsten Korth; E S Anton; Akira Sawa
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

Review 6.  Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.

Authors:  Xiangyou Hu; Qingyuan Fan; Hailong Hou; Riqiang Yan
Journal:  J Neurochem       Date:  2015-11-13       Impact factor: 5.372

7.  M1 muscarinic acetylcholine receptor interacts with BACE1 and regulates its proteosomal degradation.

Authors:  Shangtong Jiang; Yan Wang; Qilin Ma; Aina Zhou; Xian Zhang; Yun-wu Zhang
Journal:  Neurosci Lett       Date:  2012-03-19       Impact factor: 3.046

Review 8.  β-Secretase: its biology as a therapeutic target in diseases.

Authors:  Haibo Wang; Rena Li; Yong Shen
Journal:  Trends Pharmacol Sci       Date:  2013-02-27       Impact factor: 14.819

9.  Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease.

Authors:  Latha Devi; Melissa J Alldred; Stephen D Ginsberg; Masuo Ohno
Journal:  Mol Brain       Date:  2010-11-08       Impact factor: 4.041

10.  Differential neuregulin 1 cleavage in the prefrontal cortex and hippocampus in schizophrenia and bipolar disorder: preliminary findings.

Authors:  Ketan Marballi; Dianne Cruz; Peter Thompson; Consuelo Walss-Bass
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

View more
  2 in total

Review 1.  β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification.

Authors:  Harald Hampel; Simone Lista; Eugeen Vanmechelen; Henrik Zetterberg; Filippo Sean Giorgi; Alessandro Galgani; Kaj Blennow; Filippo Caraci; Brati Das; Riqiang Yan; Andrea Vergallo
Journal:  Alzheimers Res Ther       Date:  2020-10-16       Impact factor: 6.982

2.  Upregulation of vitamin D-related genes in schizophrenic patients.

Authors:  Fateme Asadzadeh Manjili; Seyed Mehdi Kalantar; Shahram Arsang-Jang; Soudeh Ghafouri-Fard; Mohammad Taheri; Arezou Sayad
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-09       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.